Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan-Feb;73(1):14-21.
doi: 10.1016/j.ihj.2020.11.003. Epub 2020 Nov 11.

Endocrine causes of heart failure: A clinical primer for cardiologists

Affiliations
Review

Endocrine causes of heart failure: A clinical primer for cardiologists

Saurav Khatiwada et al. Indian Heart J. 2021 Jan-Feb.

Abstract

Heart failure (HF) may be a presenting manifestation of a few endocrine disorders and should be considered in evaluation of heart failure causes. This clinically oriented review is an attempt to highlight the protean manifestations of heart failure in endocrine diseases which could present either as acute or chronic heart failure. Acute heart failure manifests as hypertensive crisis, Takotsubo syndrome, or as tachy/brady cardiomyopathies. Chronic heart failure could masquerade with features of hyperdynamic heart failure, or hypertrophic, restrictive or dilated cardiomyopathy. Rarely constrictive features or resistant heart failure could be the presenting feature. Isolated presentation as pulmonary hypertension and right heart failure are also documented. Good history-taking and physical examination with targeted investigations will help in the timely management for reversing the pathophysiology to a significant extent by appropriated management.

Keywords: Acromegaly; Endocrine causes; Heart failure; Hyperaldosteronism; Pheochromocytoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors Dr. Saurav Khatiwada, Dr. Hiya Boro, Dr. Faraz Ahmed Farooqui and Dr. Sarah Alam state that they have no conflict of interest.

Similar articles

Cited by

  • Panhypopituitarism Mimicking Acute Coronary Syndrome.
    Sugi Y, Mori K, Kobayashi T, Arai N, Okano M, Muramae N, Oshita T, Otsui K, Sakaguchi K. Sugi Y, et al. Intern Med. 2023 Feb 15;62(4):559-564. doi: 10.2169/internalmedicine.0031-22. Epub 2022 Jun 14. Intern Med. 2023. PMID: 35705269 Free PMC article.
  • Revisiting Secondary Dilative Cardiomyopathy.
    Kundnani NR, Di Luca F, Meche V, Sharma A, Popa MD, Nicula-Neagu M, Voinescu OR, Iacob M, Duda-Seiman DM, Dragan SR. Kundnani NR, et al. Int J Mol Sci. 2025 Apr 28;26(9):4181. doi: 10.3390/ijms26094181. Int J Mol Sci. 2025. PMID: 40362416 Free PMC article.

References

    1. Dickstein K., Authors/Task Force Members. Cohen-Solal A., Filippatos G. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaborati. Eur J Heart Fail. 2008 Oct;10(10):933–989. doi: 10.1016/j.ejheart.2008.08.005. - DOI - PubMed
    1. Binu A., Cherian K., Kapoor N., Chacko S., George O., Paul T. The heart of the matter: cardiac manifestations of endocrine disease. Indian J Endocrinol Metab. 2017;21(6):919. doi: 10.4103/ijem.IJEM_212_17. - DOI - PMC - PubMed
    1. Albakri A. Endocrine cardiomyopathy: a review and pooled analysis of pathophysiology, diagnosis and clinical management. Res Rev Insights. 2019;3(1) doi: 10.15761/RRI.1000153. - DOI
    1. Reyes H.A., Paquin J.J., Harris D.M. Pheochromocytoma, “the great masquerader,” presenting as severe acute decompensated heart failure in a young patient. Case Rep Cardiol. 2018;2018:1–5. doi: 10.1155/2018/8767801. - DOI - PMC - PubMed
    1. Zuber S.M., Kantorovich V., Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin N Am. 2011 Jun;40(2):295–311. doi: 10.1016/j.ecl.2011.02.002. - DOI - PMC - PubMed